A 2026 randomized pilot study found that a ketogenic diet improved muscle strength by 3 points and reduced fatigue by 7 points in 20 adults with myasthenia gravis over 12 weeks, compared to those eating normally. According to Gram Research analysis, the diet was safe and feasible with 75% completion rates, though researchers emphasize these early findings require confirmation in larger studies before strong recommendations can be made.
A new pilot study tested whether a ketogenic diet (high fat, low carb) could help people with myasthenia gravis, a condition that causes muscle weakness and extreme tiredness. Researchers divided 41 adults into two groups: one followed a keto diet for 12 weeks while the other ate normally. The keto group showed improvements in muscle strength, fatigue levels, and some immune markers, though the improvements were modest. While the results are promising and the diet proved safe and doable, researchers emphasize these are early findings that need confirmation in larger studies before making strong recommendations.
Key Statistics
A 2026 randomized controlled trial of 41 adults with myasthenia gravis found that those following a ketogenic diet for 12 weeks showed a 3-point improvement in muscle strength (QMG score) with an effect size of 1.29, compared to controls continuing their normal diet.
In the same 2026 pilot study, fatigue severity decreased by 7 points in the ketogenic diet group with an effect size of 1.19, suggesting substantial fatigue reduction in myasthenia gravis patients.
The 2026 myasthenia gravis ketogenic diet study reported 75% adherence and completion rates, demonstrating the diet is feasible and tolerable for most patients over a 12-week period.
Quality of life scores remained stable in the ketogenic diet group but worsened in controls during the 12-week 2026 study, suggesting the diet may have protective effects against symptom deterioration in myasthenia gravis.
The Quick Take
- What they studied: Whether eating a ketogenic diet (mostly fats and proteins, very few carbs) could reduce muscle weakness, fatigue, and improve immune function in people with myasthenia gravis.
- Who participated: 41 adults with generalized myasthenia gravis (a condition affecting muscles throughout the body). The keto group had 20 people, and the control group had 21 people who ate their normal diet.
- Key finding: People on the keto diet showed meaningful improvements in muscle strength (3-point improvement on a standard test) and fatigue (7-point improvement) compared to those eating normally, with moderate to large effect sizes suggesting real benefits.
- What it means for you: If you have myasthenia gravis, a ketogenic diet might help reduce symptoms, but this is early-stage research. Talk to your doctor before making major diet changes, as this study is small and needs larger confirmation studies.
The Research Details
This was a randomized controlled trial, which is a gold-standard research design. Researchers randomly assigned 41 adults with generalized myasthenia gravis to either follow a ketogenic diet or continue eating their normal diet for 12 weeks. The ketogenic diet is very high in fats and proteins but extremely low in carbohydrates, which forces the body to burn fat for energy instead of sugar.
The study was “open-label,” meaning both the participants and researchers knew who was following the keto diet and who wasn’t. This is different from a “blinded” study where people don’t know which group they’re in, which can reduce bias. Researchers measured multiple outcomes including muscle strength, fatigue levels, quality of life, and blood markers related to immune function and nerve damage.
The study lasted 12 weeks, which is a relatively short timeframe for evaluating long-term dietary effects. Researchers tracked how well people stuck with the diet (75% completed the study) and looked for any safety concerns.
This research design matters because myasthenia gravis is a serious autoimmune condition where the body’s immune system attacks the connection between nerves and muscles. Finding safe, dietary approaches that might reduce symptoms could help people manage their condition alongside standard medications. The randomized design helps show whether improvements come from the diet itself rather than just from extra attention or placebo effects.
This is a pilot study, meaning it’s designed to test whether something is feasible and safe before investing in larger research. The sample size of 41 people is relatively small, which limits how confident we can be in the results. The study was not blinded, so expectations and attention could have influenced outcomes. However, the study was published in a reputable journal (Journal of Autoimmunity), used standardized measurement tools, and included both clinical and biological markers, which strengthens its credibility.
What the Results Show
The primary measure was the Myasthenia Gravis-Activities of Daily Living (MG-ADL) score, which tracks how much muscle weakness affects everyday tasks. The keto group showed a median improvement of 2 points, though the confidence interval included zero, meaning this result wasn’t statistically certain.
For muscle strength measured by the Quantitative Myasthenia Gravis (QMG) test, the keto group improved by 3 points with a strong effect size of 1.29, suggesting a meaningful real-world improvement. Fatigue, measured on the Fatigue Severity Scale, decreased by 7 points in the keto group with an effect size of 1.19, indicating substantial fatigue reduction.
Quality of life scores remained stable in the keto group but worsened in the control group, suggesting the diet may have protective effects. Additionally, 75% of participants completed the full 12-week study, demonstrating the diet was feasible and tolerable for most people.
Blood tests showed a numerical decrease in calprotectin (a marker of inflammation), though the change wasn’t dramatic. Serum neurofilament light chain, a marker of nerve damage, remained unchanged in both groups. T-cell subsets (immune cells) showed exploratory changes, but researchers were cautious about interpreting these without larger confirmation. The Patient Acceptable Symptom State (PASS) measure—asking whether patients felt their symptoms were acceptable—remained stable in the keto group but worsened in controls, suggesting the diet prevented symptom deterioration.
This is one of the first studies examining ketogenic diet effects in myasthenia gravis specifically. Previous research has shown ketogenic diets may have anti-inflammatory and neuroprotective effects in other neurological conditions like epilepsy and Parkinson’s disease. This pilot study suggests similar mechanisms might benefit myasthenia gravis, but direct comparisons are limited because few prior studies have examined this combination.
The study is small (41 people total), which limits how much we can generalize findings to all myasthenia gravis patients. The study wasn’t blinded, so participants and researchers knew who was on the keto diet, which could create bias. The 12-week timeframe is relatively short for evaluating dietary interventions. Some improvements, like the MG-ADL score, had confidence intervals that included zero, meaning they weren’t statistically certain. The study didn’t track long-term adherence beyond 12 weeks or examine whether benefits persist after stopping the diet. Researchers explicitly state these are exploratory findings requiring confirmation in larger, blinded studies.
The Bottom Line
Based on this pilot study, a ketogenic diet appears safe and feasible for people with myasthenia gravis and shows promise for reducing fatigue and improving muscle strength. However, confidence in these recommendations is moderate to low because this is a small pilot study. Anyone with myasthenia gravis considering a ketogenic diet should discuss it with their neurologist first, as the diet is restrictive and may interact with medications. This should complement, not replace, standard medical treatment.
People with generalized myasthenia gravis who are interested in dietary approaches to manage symptoms should pay attention to this research. Those struggling with fatigue or muscle weakness despite medication might find this particularly relevant. However, people with myasthenia gravis who have difficulty adhering to restrictive diets, those with other medical conditions requiring different diets, or those taking medications that interact with ketogenic diets should be cautious. This research is not yet applicable to other conditions.
In this 12-week study, improvements in fatigue and muscle strength appeared within the study period. However, realistic expectations suggest it may take 4-8 weeks to notice meaningful changes, as the body adapts to ketogenic metabolism. Benefits may continue to improve beyond 12 weeks, but this hasn’t been studied yet. If no improvement occurs within 8-12 weeks, the diet may not be beneficial for that individual.
Frequently Asked Questions
Can a keto diet help with myasthenia gravis symptoms?
A 2026 pilot study found that people with myasthenia gravis on a ketogenic diet showed improvements in muscle strength and fatigue over 12 weeks compared to those eating normally. However, this is early research requiring larger confirmation studies before definitive recommendations.
How much can a ketogenic diet reduce fatigue in myasthenia gravis?
In the 2026 pilot study, fatigue decreased by 7 points on the Fatigue Severity Scale in the keto group, representing a substantial reduction. However, individual results vary, and this small study needs confirmation in larger populations.
Is a ketogenic diet safe for people with myasthenia gravis?
The 2026 pilot study found the ketogenic diet was safe and feasible, with 75% of participants completing the 12-week program without serious adverse effects. However, anyone considering this diet should consult their neurologist first, as it’s restrictive and may interact with medications.
How long does it take to see benefits from a keto diet with myasthenia gravis?
The 2026 study observed improvements within 12 weeks, but realistic expectations suggest 4-8 weeks may be needed to notice meaningful changes as the body adapts to ketogenic metabolism. Individual timelines vary considerably.
Should I replace my myasthenia gravis medication with a ketogenic diet?
No. The 2026 pilot study shows the ketogenic diet as a potential complement to standard medical treatment, not a replacement. Always continue prescribed medications and discuss any dietary changes with your neurologist before starting.
Want to Apply This Research?
- Track daily fatigue levels (1-10 scale) and specific muscle weakness symptoms (e.g., difficulty climbing stairs, holding objects) three times weekly. Also monitor diet adherence by logging meals to ensure ketogenic macronutrient targets are met (typically 70-75% fat, 20-25% protein, 5-10% carbs).
- Users can start by replacing one meal daily with a keto-friendly option (eggs with avocado, fatty fish with vegetables, full-fat dairy) while maintaining their current medications. Gradually increase keto meals over 2-3 weeks to allow the body to adapt, monitoring symptoms throughout.
- Create a weekly dashboard showing fatigue trends, muscle strength in specific activities, and diet adherence percentage. Set reminders for symptom logging and weekly check-ins with medication timing to ensure no interactions. Compare month-to-month trends rather than day-to-day fluctuations, as myasthenia gravis symptoms naturally vary.
This research is a small pilot study and should not be considered definitive medical advice. The findings are preliminary and require confirmation in larger, blinded studies. Anyone with myasthenia gravis considering a ketogenic diet should consult their neurologist or healthcare provider before making dietary changes, as this diet is restrictive and may interact with medications used to treat myasthenia gravis. This diet should complement, not replace, standard medical treatment. Individual results vary, and what works for one person may not work for another. Always discuss major dietary changes with your healthcare team.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.